User preference for a portable syringe pump for iloprost infusion

PURPOSE: Administration of intravenous iloprost – a first-line European League Against Rheumatism (EULAR)-recommended choice for the treatment of scleroderma (SSc)-related digital vasculopathy – requires repeated treatment cycles of 6 hours per day in a hospital setting. During the infusion, patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Laria, Antonella, Lurati, Alfredo Maria, Re, Katia Angela, Marrazza, Maria Grazia, Mazzocchi, Daniela, Farina, Alberto, Scarpellini, Magda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447001/
https://www.ncbi.nlm.nih.gov/pubmed/26056502
http://dx.doi.org/10.2147/PROM.S81473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447001/
https://www.ncbi.nlm.nih.gov/pubmed/26056502
http://dx.doi.org/10.2147/PROM.S81473

Ejemplares similares